Chris Cadman
From advanced drug formulations to new active pharmaceutical ingredients, Chris helps companies navigate the complexities of bringing new pharmaceutical technologies to market. Since 2018, he has played a key role in establishing and growing Potter Clarkson's Stockholm office.
Chris has significant expertise in managing global portfolios that support the protection of marketed pharmaceutical products, and in devising and implementing multi-jurisdictional litigation strategies.
Chris joined Potter Clarkson in 2014 and, since 2018, has played a key role in the Stockholm office, advising clients across the Nordic region.
He is passionate about helping businesses make the most of their intellectual property (IP) and ensuring it supports their business goals.
- Developing robust IP strategies for pharmaceutical companies
- Handling global portfolios for marketed pharmaceutical products
- Devising and implementing multi-jurisdictional litigation strategies
- IP due diligence
- UK and European Patent Attorney
- PHD
- BSc
Chris has been instrumental in safeguarding our pharmaceutical innovations. His expertise in global patent portfolio management and litigation strategies has helped us maintain a competitive edge in the market, and we are grateful for the peace of mind he brings to our IP management.
Chemistry and pharmaceuticals ace Cadman has carved a niche for himself among those active in the novel small molecule compounds and drug formulations sphere. His deep understanding of start-ups' needs has also attracted players from the medical devices sector.
- IAM Patent 1000: Prosecution
- Managing IP EMEA Awards 2024: Sweden Practitioner of the Year (Nominee)
- MIP IP STARS: Notable Practitioner
- MIP IP STARS: Rising Star
About Chris
Experience
Areas of expertise
Qualifications
Testimonials
Awards
How We Live Our Values: Excellence
My expertise in patent prosecution and enforcement, along with experience conducting IP due diligence for both companies and investors, allows me to support clients across the pharmaceutical sector. I focus on delivering advice that adds commercial value and helps clients make confident, well-informed decisions.
In My Own Words
In 2018, I was offered the exciting opportunity to move to Sweden to help set up our Stockholm office, and I have not looked back since. Sweden is globally recognised as a leader in life sciences, and being based in Stockholm has allowed me to work closely with many world-leading pharmaceutical and life science companies in the region.
Since opening, the office has gone from strength to strength, and I am proud to have taken a leading role in its development, contributing to its success and building strong partnerships within the industry. The future of the Swedish life science sector looks incredibly bright, with continuous advancements and innovations on the horizon. I am excited about what the future holds and look forward to continuing to support our clients and ensuring their intellectual property is well protected and aligned with their business goals.
Related News
Potter Clarkson ranked in Managing IP's IP STARS 2025
IAM Patent 1000: The World's Leading Patent Professionals 2025
IAM Patent 1000: The World's Leading Patent Professionals 2024
Managing IP IP STARS 2024
Potter Clarkson nominated for 11 Managing IP Awards 2024
.avif)
Another US patent litigation win for Orexo AB’s ZUBSOLV®
Managing IP IP STARS 2023
